Literature DB >> 56646

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs.

T E Starzl, K Watanabe, K A Porter, C W Putnam.   

Abstract

Insulin, glucagon, and insulin/glucagon mixtures have been infused for four days into the left portal vein of dogs after portacaval shunt. In the left but not in the right liver lobes, insulin alone reduced atrophy, preserved hepatocyte ultrastructure, and trebled cell renewal. Glucagon alone had no effect. In small doses, glucagon did not potentiate the action of insulin and in large doses it may have reduced the insulin benefit. These studies explain the development of the previously mysterious Eck fistula syndrome, provide clues about in-vivo cell growth control by hormones, and suggests new lines of inquiry about the pathogenesis and/or treatment of several human disease processes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56646     DOI: 10.1016/s0140-6736(76)90477-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  81 in total

1.  The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions.

Authors:  J Hayakawa; H Motohashi; M Sairenji; O Kobayashi; M Takahashi; Y Usuda
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

2.  The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967).

Authors:  Thomas E Starzl
Journal:  J Am Coll Surg       Date:  2002-11       Impact factor: 6.113

3.  Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors.

Authors:  A Francavilla; A Azzarone; G Carrieri; C Scotti-Foglieni; Q H Zeng; U Cillo; K Porter; T E Starzl
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

4.  Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.

Authors:  A Azzarone; A Francavilla; G Carrieri; A Gasbarrini; C Scotti-Foglieni; S Fagiuoli; U Cillo; Q H Zeng; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

Review 5.  Cellular transplantation and gene therapy.

Authors:  C Ricordi; S T Ildstad; T E Starzl
Journal:  Clin Transplant       Date:  1993-02       Impact factor: 2.863

Review 6.  Themes of liver transplantation.

Authors:  Thomas E Starzl; John J Fung
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

7.  Liver regeneration in dogs: morphologic and chemical changes.

Authors:  A Francavilla; K A Porter; J Benichou; A F Jones; T E Starzl
Journal:  J Surg Res       Date:  1978-11       Impact factor: 2.192

8.  Insulin and glucagon therapy of acute hepatic failure.

Authors:  K Fujiwara; I Ogata; Y Sato; T Tomiya; Y Ohta; Y Oka; S Nagoshi; S Yamada; N Masaki; K Takatsuki
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

9.  Studies of the hepatotrophic qualities of FK 506 and CyA.

Authors:  V Mazzaferro; C L Scotti-Foglieni; K A Porter; J Trejo Bellido; G Carrieri; S Todo; J J Fung; A Francavilla; T E Starzl
Journal:  Transplant Proc       Date:  1990-02       Impact factor: 1.066

10.  Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Vladimir M Subbotin; Tadahiro Uemura; Michael Nalesnik; Anthony J Demetris; John J Fung; Thomas E Starzl
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.